Healthfinch raises $7.5M in Series A funding for EHR-integrated software platform; Patients often don't understand discharge plans;

News From Around the Web

> Madison, Wisconsin-based Healthfinch, co-founded by Chicago-based physician Lyle Berkowitz, raised $7.5 million in Series A funding to build out "Charlie," an electronic medical record-integrated software platform built to help health systems automate and delegate tasks, the Chicago Tribune reports. Article

Provider News

> Most patients don't understand their post-discharge care plans because they're written for those with advanced reading skills, a new study finds. Discharge notes should be understandable for those reading at a sixth-grade level, the researchers said. Article

> President Barack Obama's gun control initiative will lead to a modification of the HIPAA Privacy Rule to allow certain covered entities to disclose to the National Instant Criminal Background Check System (NICS) the identities of those individuals who, for specific mental health reasons, already are prohibited by federal law from having a firearm. Post

Mobile Healthcare News

The next four years will bring a seismic shift in connected healthcare technology, with an increased emphasis on chronic condition management, personal fitness and wellness and remote patient monitoring, according to a new report. Article

> Researchers are investigating the use of mobile digital health tools to help kidney transplant patients adhere to medication intake, monitor blood pressure and avoid premature graft loss following surgery. The Medical University of South Carolina team is undertaking the research thanks to a $1.11 million National Institutes of Health grant. Article

And Finally... I would say the coach wasn't using his head, but that would be inaccurate. Article

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.